Meropenem
Top View
- The Treatment of Melioidosis
- Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
- Teflaro™ (Ceftaroline Fosamil)
- Handbook of Outpatient Parenteral Antimicrobial Therapy (OPAT)
- Meropenem Meropenem Was Administered to Dams from Gestation Day 17 Until Lactation Day 21 at 83 to 140) for the 1 Gram Dose
- Guideline for Treatment of Bacterial Meningitis in Adults
- Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and Its Newer Rela Ves
- Β-Lactam Susceptibility of Escherichia Coli Isolates from Urinary Tract Infections Exhibiting Different Resistance Phenotypes
- Penicillin Allergy: a Practical Approach to Assessment and Prescribing
- Zinforo, INN-Ceftaroline Fosamil
- Versus Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- and XDR-TB
- Evaluation of Polymyxin B-Based and Dual- Carbapenem Combinations Against Carbapenem-Resistant Enterobacteriaceae Co- Harbouring Mcr-1 and KPC-2
- Use of Carbapenems in Children Summary Carbapenems Are Betalactams with the Broadest Antibacterial Spectrum Currently Available
- Activity of Aztreonam Combined with the Beta-Lactamase Inhibitor Avibactam Tested Against Metallo-Β-Lactamase-Producing Organisms
- Penicillin Allergy Is Often Over Reported
- Antibiotics in Sepsis: the Basics
- Double Anaerobic Coverage: What Is the Role in Clinical Practice?
- Expanded Antimicrobial Susceptibility Testing for Hard-To-Treat Infections